Stay updated on Tirzepatide in HFpEF & Obesity Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in HFpEF & Obesity Clinical Trial page.

Latest updates to the Tirzepatide in HFpEF & Obesity Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new site revision label v3.6.4 was added, replacing the previous v3.6.3. This reflects an updated build/version tag shown on the page.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new publication citation is added to the Publications section for a prespecified secondary analysis from the SUMMIT trial. The entry describes Tirzepatide effects in obesity-related HFpEF by sex.SummaryDifference0.0%

- Check30 days agoChange DetectedRevision: v3.6.3 now appears on the page, replacing the previous v3.6.2. This indicates a minor page update or QC change to the study listing rather than new study content.SummaryDifference0.0%

- Check37 days agoChange DetectedA new citation from Diabetes Obes Metab (2024) is added to the Publications section. The study record revision is updated from v3.6.0 to v3.6.2.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page adds a recruitment status notice ('No longer looking for participants') and introduces new help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'), and updates the Intervention/Treatment heading along with a new revision note ('Revision: v3.6.0'). It removes the older 'Intervention / Treatment' heading and the old revision note ('Revision: v3.5.5').SummaryDifference0.2%

- Check58 days agoChange DetectedRevision: v3.5.5 was added and Revision: v3.5.4 was removed, signaling a minor page/template update. This change updates the version label but does not modify the study content or details presented on the page.SummaryDifference0.0%

Stay in the know with updates to Tirzepatide in HFpEF & Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in HFpEF & Obesity Clinical Trial page.